Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 17/20 | 0.56 |
| ▸ | SLC5A1 | P13866 | 6/20 | 0.52 |
| ▸ | SELL | P14151 | 1/20 | 0.46 |
| ▸ | SELP | P16109 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22314236 | 0.82 | SLC5A2 (0.59) | SLC5A2SLC5A1SELLSELPACHE | |
| SCHEMBL22314229 | 0.82 | SLC5A2 (0.59) | SLC5A2SLC5A1SELLSELPACHE | |
| SCHEMBL26192723 | 0.82 | SLC5A2 (0.59) | SLC5A2SLC5A1SELLSELPACHE | |
| SCHEMBL12426196 | 0.80 | SLC5A2 (0.59) | SLC5A2SLC5A1 | |
| SCHEMBL12662679 | 0.80 | SLC5A2 (0.59) | SLC5A2SLC5A1 | |
| SCHEMBL12426214 | 0.80 | SLC5A2 (0.59) | SLC5A2SLC5A1 | |
| SCHEMBL14049265 | 0.80 | SLC5A2 (0.59) | SLC5A2SLC5A1 | |
| SCHEMBL14049245 | 0.80 | SLC5A2 (0.59) | SLC5A2SLC5A1 | |
| SCHEMBL22796964 | 0.79 | P2RY2 (0.59) | — | |
| SCHEMBL1854535 | 0.76 | SLC5A2 (0.75) | SLC5A2SLC5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200392550-A1 | REAGENTS AND METHODS FOR REPLICATION, TRANSCRIPTION, AND TRANSLATION IN SEMI-SYNTHETIC ORGANISMS | THE SCRIPPS RESEARCH INSTITUTE | 2020-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200392550-A1 | REAGENTS AND METHODS FOR REPLICATION, TRANSCRIPTION, AND TRANSLATION IN SEMI-SYNTHETIC ORGANISMS | RNGTT, MAX, POLRMT | SLC5A2 4484/4885SLC5A1 4515/4885SELL 4030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.